ScienceAlert on MSN
'Junk' DNA Could Be Recruited to Destroy Cancer Cells From Within
Sections of DNA once dismissed as dormant and useless could in fact be recruited to fight certain types of drug-resistant ...
Cancer patients who got an mRNA COVID vaccine within a few months of their immunotherapy lived longer than those who did not, health records show.
The use of immunotherapy in patients with various types of cancer has led to dramatic increases in survival. Increased median ...
Researchers at the UT Austin Portugal Program have developed what they say is a remarkable cancer treatment that combines LED ...
As humans age, we become more vulnerable to cancer and other diseases. Bowhead whales, however, can live for up to 200 years ...
THE WOODLANDS, Texas, and CAMBRIDGE, Mass., Oct. 29, 2025 /PRNewswire/ -- Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), today announced it ...
The winner of a 2025 SITC grant examines mechanisms that may help explain why drugs that work for some forms of lymphoma ...
(HealthDay News) — Macrovascular infiltration and spikes in circulating tumor cell (CTC) clusters are associated with cancer mortality, according to a study published online Oct. 16 in Nature Medicine ...
Merck and Eisai's experimental combination treatment for a type of kidney cancer met one of the main goals in a late-stage ...
As Merck looks for growth opportunities ahead of Keytruda’s tumble over the patent cliff, the company’s future now looks a ...
‘Incredibly Encouraging’ Drug Trial Shrinks Tumors in Head and Neck Cancer Patients Within Six Weeks
But with amivantamab, they have an “incredibly encouraging” new option that was shown in a trial conducted across 11 ...
Advances in cancer immunotherapy from immune checkpoint modulation to adoptive cell transfer of tumour-infiltrating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results